REXULTI Drug General Use-results Survey (Excessive Motor Activity or Physically/Verbally Aggressive Behavior Due to Rapid Changes in Mood, Irritability, and/or Outbursts Associated With Dementia Due to Alzheimer's Disease)

NCT06875986 · clinicaltrials.gov ↗

RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: Brexpiprazole (Rexulti)

Sponsor

Otsuka Pharmaceutical Co., Ltd.